177 related articles for article (PubMed ID: 27150988)
21. [Study on the Mechanism of Multi-Drug Resistance of Agaricus Blazei Extract FA-2-b-β Mediated Wnt Signaling Pathway to Reverse Acute T Lymphoblastic Leukemia].
Feng WW; Bai Y; Wang DP; Fan FY; Sun YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):621-627. PubMed ID: 37356917
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
23. [Detecting HB-1 Expression Level in Bone Marrow of Acute Leukemia Patients by Real-Time Fluorescence Quantitative RT-PCR].
Wang QY; Li Y; Ji L; Liang ZY; Liu W; Ren HY; Qiu ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):8-15. PubMed ID: 29397811
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.
Hu Y; Pu Q; Cui B; Lin J
Int J Clin Exp Pathol; 2015; 8(8):8921-8. PubMed ID: 26464633
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line.
Najjary S; Mohammadzadeh R; Mansoori B; Vahidian F; Mohammadi A; Doustvandi MA; Khaze V; Hajiasgharzadeh K; Baradaran B
Med Oncol; 2021 Oct; 38(12):142. PubMed ID: 34655330
[TBL] [Abstract][Full Text] [Related]
26. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
Wang Y; Han ZX; Zhang JC
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
[No Abstract] [Full Text] [Related]
27. [Effects of microRNA-34a on regulating silent information regulator 1 and influence of the factor on myocardial damage of rats with severe burns at early stage].
Bai XZ; He T; Zhang JL; Liu Y; Cao MY; Zhang JN; Cai WX; Jia YH; Shi JH; Su LL; Hu DH
Zhonghua Shao Shang Za Zhi; 2018 Jan; 34(1):21-28. PubMed ID: 29374923
[No Abstract] [Full Text] [Related]
28. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
29. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
Lv T; Song K; Zhang L; Li W; Chen Y; Diao Y; Yao Q; Liu P
Biochem Cell Biol; 2018 Oct; 96(5):663-671. PubMed ID: 29561664
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway.
Wang XP; Zhou J; Han M; Chen CB; Zheng YT; He XS; Yuan XP
Oncotarget; 2017 Feb; 8(8):13264-13276. PubMed ID: 28129650
[TBL] [Abstract][Full Text] [Related]
31. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
33. [microRNAs expression profile in acute promyelocytic leukemia cell differentiation induced by all-trans retinoic acid and arsenic trioxide].
Wu Y; Li XF; Yang JH; Liao XY; Chen YZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):546-51. PubMed ID: 22967415
[TBL] [Abstract][Full Text] [Related]
34. miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.
Lucafò M; Sicari D; Chicco A; Curci D; Bellazzo A; Di Silvestre A; Pegolo C; Autry R; Cecchin E; De Iudicibus S; Collavin L; Evans W; Decorti G; Stocco G
Cancer Chemother Pharmacol; 2020 Sep; 86(3):361-374. PubMed ID: 32776229
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
36. [Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia].
Wang C; Chen FY; Zhu JS; Xu YP; Han JY; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):845-8. PubMed ID: 15634546
[TBL] [Abstract][Full Text] [Related]
37. [Expression of miR-155 in Acute Myeloid Leukemia and Its Clinical Significance].
Hu XL; Tang AP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):980-4. PubMed ID: 27531760
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mircoRNA-34a Enhances Survival of Human Bone Marrow Mesenchymal Stromal/Stem Cells Under Oxidative Stress.
Liu Y; Zhang X; Chen J; Li T
Med Sci Monit; 2018 Jan; 24():264-271. PubMed ID: 29331104
[TBL] [Abstract][Full Text] [Related]
39. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
40. [Application of miR-182 for Determination of Glucocorticoid-Resistant Patients with Lymphoid Malignancy].
Hu YW; Chen SY; Xie YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):781-785. PubMed ID: 28641635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
